Decision Management International (“DMI”) is a global software and professional services provider focused on serving FDA regulated industries. To date, DMI has successfully completed over 300 projects for approximately 100 facilities of client companies, which include many of the leading companies in the pharmaceutical, biotechnology and medical device industries. DMI provides customers with integrated, efficient and cost effective software and consulting solutions used in the manufacture of FDA regulated products. DMI’s proprietary software solutions and consulting services benefit customers in many ways, including reducing process complexity and paperwork, streamlining documentation and approval processes, improving manufacturing yields and efficiencies, reducing errors, enhancing regulatory compliance, shortening product development cycles, reducing the probability of costly product recalls, and reducing production costs.
has sold $14M Series A Convertible Preferred Stock to
The undersigned acted as the exclusive placement agent to Decision Management Int'l for this private equity transaction.